Skip to main content
. 2019 Apr 5;9:5695. doi: 10.1038/s41598-019-42131-y

Figure 1.

Figure 1

Nuclear Skp2 expression is associated with a high Gleason score in prostate cancer patients. (A) Patient samples from primary prostate carcinoma and benign hyperplasia were stained with anti-Skp2 antibody. Magnification: 40×. (B) Correlation of Skp2 with Gleason score. (C) Correlation of EMT-related marker (E-cadherin and vimentin) expression with Gleason score.